CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.
Gamell C, Bankovacki A, Scalzo-Inguanti K, Sedgmen B, Alhamdoosh M, Gail E, Turkovic L, Millar C, Johnson L, Wahlsten M, Richter J, Schuster J, Dyson A, Nicolopoulos J, Varigos G, Ng M, Wilson N, Field J, Kern JS, Lindqvist LM.
Gamell C, et al. Among authors: field j.
Br J Dermatol. 2023 Apr 20;188(5):636-648. doi: 10.1093/bjd/ljad013.
Br J Dermatol. 2023.
PMID: 36691791
Clinical Trial.